Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and Antiretroviral Therapy (ART)

Trial Profile

Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and Antiretroviral Therapy (ART)

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Jul 2017

At a glance

  • Drugs Atazanavir/ritonavir (Primary) ; Efavirenz (Primary) ; Ethinylestradiol/etonogestrel (Primary) ; RNA-directed DNA polymerase inhibitors; Tenofovir
  • Indications HIV-1 infections; Pregnancy
  • Focus Pharmacokinetics
  • Most Recent Events

    • 24 Jan 2017 Status changed from recruiting to completed.
    • 20 Sep 2016 Planned End Date changed from 1 Sep 2016 to 1 Dec 2016.
    • 20 Sep 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Nov 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top